Janus Henderson Contrarian Fund - T Shares
Janus Henderson Contrarian Fund - T Shares (JSVAX)
The Janus Henderson Contrarian Fund primarily allocates at least 80% of its net assets (including any funds borrowed for investment) to equity securities, with the objective of generating long-term capital appreciation. The portfolio manager employs a strategy of identifying and investing in companies whose shares are trading at a substantial discount to their estimated intrinsic value, anticipating that this inherent worth will appreciate over time. The fund's holdings are not restricted by company size; it can encompass enterprises ranging from large, established market leaders to smaller, rapidly expanding firms. Furthermore, the portfolio has the flexibility to include international securities, potentially extending to investments within developing or emerging market economies. Notably, the fund operates on a non-diversified basis.
JSVAX Mutual Fund Chart & Stats
- Previous Close
- $30.27
- Sub-Category
- Value
- Total Liabilities
- $23.34M
- Last Dividend Ex-Date
- Dec 05, 2025
- Expense Ratio
- 0.77%
- Holding Count
- 40
- Brand
- Janus Investment Fund
- Dividend Yield
- (9.76%)
- Category
- Equity
- Total Assets
- 5.51B
- Shares Outstanding
- N/A
- 52-Week Range
- $24.38 - $33.54
JSVAX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| NBISNebius Group N.V. | 5.76% |
| MRVLMarvell Technology Group | 5.53% |
| TSMTaiwan Semiconductor Manufacturing Company Limited | 5.40% |
| PNCPNC Financial Services | 4.35% |
| COFCapital One Financial Corp. | 4.35% |
| SGRYSurgery Partners Inc. | 4.06% |
| UNHUnitedhealth Group Inc. | 4.05% |
| LITELumentum Holdings Inc | 3.98% |
| ORCLOracle Corporation | 3.83% |
| HWMHowmet Aerospace Inc. | 3.75% |
| Total | 45.09% |
Recently Viewed
No data currently available






